Brenda Finucane is associate director of the Autism and Developmental Medicine Institute at Geisinger in Lewisburg, Pennsylvania.

Brenda Finucane
Associate director
Autism and Developmental Medicine Institute at Geisinger
From this contributor
Q&A with Brenda Finucane: Building pipelines for genetic tests for autism
Most autistic people do not receive the medically recommended genetic tests for autism. Brenda Finucane and her colleagues want to change that.

Q&A with Brenda Finucane: Building pipelines for genetic tests for autism
Explore more from The Transmitter
The visual system’s lingering mystery: Connecting neural activity and perception
Figuring out how the brain uses information from visual neurons may require new tools. I asked 10 neuroscientists what experimental and conceptual methods they think we’re missing.

The visual system’s lingering mystery: Connecting neural activity and perception
Figuring out how the brain uses information from visual neurons may require new tools. I asked 10 neuroscientists what experimental and conceptual methods they think we’re missing.
New questions around motor neurons and plasticity
A researcher’s theory hangs muscle degeneration on a broken neural circuit.

New questions around motor neurons and plasticity
A researcher’s theory hangs muscle degeneration on a broken neural circuit.
Boosting SCN2A expression reduces seizures in mice
A modified form of CRISPR amps up expression of the gene—a strategy that could apply to other gene variations linked to autism.

Boosting SCN2A expression reduces seizures in mice
A modified form of CRISPR amps up expression of the gene—a strategy that could apply to other gene variations linked to autism.